SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 38 filers reported holding SAB BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $140 | -99.9% | 236,621 | -14.0% | 0.00% | -20.0% |
| Q3 2022 | $193,000 | -51.6% | 275,000 | 0.0% | 0.01% | -50.0% |
| Q2 2022 | $399,000 | -61.4% | 275,000 | 0.0% | 0.01% | -61.5% |
| Q1 2022 | $1,034,000 | -44.8% | 275,000 | +14.7% | 0.03% | -45.8% |
| Q4 2021 | $1,872,000 | – | 239,750 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First PREMIER Bank | 652,440 | $946,000 | 0.28% |
| METEORA CAPITAL, LLC | 292,538 | $424,000 | 0.08% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 78,115 | $113,000 | 0.02% |
| SILVER OAK SECURITIES, Inc | 51,941 | $64,000 | 0.01% |
| Shaolin Capital Management LLC | 275,000 | $399,000 | 0.01% |
| Elgethun Capital Management | 13,296 | $18,000 | 0.01% |
| LGL PARTNERS, LLC | 23,000 | $33,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,000 | $122,000 | 0.00% |
| Spectrum Management Group, LLC | 5,030 | $7,000 | 0.00% |
| Veritable, L.P. | 43,551 | $63,000 | 0.00% |